Mikkel Thor Olsen, Malene Elbæk Vikner, Signe Hjejle Jensen, Louise Mathorne Rasmussen, Carina Kirstine Klarskov, Birgitte Lindegaard, Jonas Askø Andersen, Hans Gottlieb, Suzanne Lunding, Kirsten Nørgaard, Ulrik Pedersen-Bjergaard, Katrine Bagge Hansen, Peter Lommer Kristensen
{"title":"Satisfaction with continuous glucose monitoring and diabetes care among hospitalised patients with type 2 diabetes managed by inpatient diabetes teams","authors":"Mikkel Thor Olsen, Malene Elbæk Vikner, Signe Hjejle Jensen, Louise Mathorne Rasmussen, Carina Kirstine Klarskov, Birgitte Lindegaard, Jonas Askø Andersen, Hans Gottlieb, Suzanne Lunding, Kirsten Nørgaard, Ulrik Pedersen-Bjergaard, Katrine Bagge Hansen, Peter Lommer Kristensen","doi":"10.1111/dme.70114","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>Continuous glucose monitoring (CGM) is increasingly recognised as a valuable tool in the hospital setting, with evidence supporting its accuracy and potential for improving glycaemic and clinical outcomes. However, patient perspectives on the use of CGM in the hospital setting remain underexplored. This study investigates patient satisfaction with CGM during hospitalisation.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This analysis included 166 hospitalised non-intensive care unit (non-ICU) patients with type 2 diabetes from the DIAbetes TEam and Cgm (DIATEC) trial. Participants were randomised to either point-of-care (POC) glucose testing (<i>n</i> = 82) or CGM (<i>n</i> = 84) for glucose monitoring during their hospital stay and were managed by inpatient diabetes teams. At discharge, patients completed a survey developed for this specific study, assessing their satisfaction with the diabetes management, with a focus on glucose monitoring methods.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Overall satisfaction with the diabetes treatment during hospitalisation was similar in both groups, with 77% of patients in each group reporting being satisfied or very satisfied (<i>p</i> = 0.188). Regarding glucose assessment, 75% in the CGM group preferred CGM over POC glucose testing (<i>p</i> < 0.001). In the CGM group, 95% felt comfortable with CGM being the primary method for glucose management (<i>p</i> < 0.001). Approximately 5% reported discomfort from wearing the CGM, mainly due to itching from the sensor. Most patients (95%) in both groups were comfortable with their diabetes management being handled by inpatient diabetes teams (<i>p</i> < 0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Satisfaction with CGM among non-ICU patients with type 2 diabetes managed by inpatient diabetes teams was high, highlighting CGM's potential to enhance patient care in the hospital setting.</p>\n </section>\n </div>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":"42 10","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetic Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/dme.70114","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
Continuous glucose monitoring (CGM) is increasingly recognised as a valuable tool in the hospital setting, with evidence supporting its accuracy and potential for improving glycaemic and clinical outcomes. However, patient perspectives on the use of CGM in the hospital setting remain underexplored. This study investigates patient satisfaction with CGM during hospitalisation.
Methods
This analysis included 166 hospitalised non-intensive care unit (non-ICU) patients with type 2 diabetes from the DIAbetes TEam and Cgm (DIATEC) trial. Participants were randomised to either point-of-care (POC) glucose testing (n = 82) or CGM (n = 84) for glucose monitoring during their hospital stay and were managed by inpatient diabetes teams. At discharge, patients completed a survey developed for this specific study, assessing their satisfaction with the diabetes management, with a focus on glucose monitoring methods.
Results
Overall satisfaction with the diabetes treatment during hospitalisation was similar in both groups, with 77% of patients in each group reporting being satisfied or very satisfied (p = 0.188). Regarding glucose assessment, 75% in the CGM group preferred CGM over POC glucose testing (p < 0.001). In the CGM group, 95% felt comfortable with CGM being the primary method for glucose management (p < 0.001). Approximately 5% reported discomfort from wearing the CGM, mainly due to itching from the sensor. Most patients (95%) in both groups were comfortable with their diabetes management being handled by inpatient diabetes teams (p < 0.001).
Conclusions
Satisfaction with CGM among non-ICU patients with type 2 diabetes managed by inpatient diabetes teams was high, highlighting CGM's potential to enhance patient care in the hospital setting.
期刊介绍:
Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions.
The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed.
We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services.
Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”